Literature DB >> 21131300

Changes in PGRMC1, a potential progesterone receptor, in human myometrium during pregnancy and labour at term and preterm.

Wen Wu1, Shao-Qing Shi, Han-Ju Huang, J Balducci, Robert E Garfield.   

Abstract

This study assesses the role of progesterone receptor membrane component 1 (PGRMC1) in actions of progesterone (P4) on human myometrium during pregnancy and labour. Myometrial tissues were obtained from non-pregnant patients during hysterectomy or pregnant women undergoing C-section at term and preterm, before and during labour. PGRMC1 expression in myometrial tissues and in a human myometrial cell line (HM9) was assessed by western blots and RT-PCR. The subcellular localization of PGRMC1 in HM9 was performed by immunofluorescence staining. Isometric contractions of myometrial tissues were obtained in response to P4 with and without addition of specific antibodies against PGRMC1. Endogenous and over-expressed PGRMC1 proteins are detected by western blots in myometrial tissues, HM9 and 293 cells, respectively. PGRMC1 is localized to the plasma membrane, cytoplasm and nuclear membranes. PGRMC1 is lower in myometrium of women at term either not in labour (P = 0.004) or in labour (P = 0.005) compared with tissues from women in preterm non-labour. PGRMC1 levels are also decreased (P = 0.02) in myometrial tissues from women during preterm labour compared with preterm non-labour. P4 rapidly inhibits contractions of myometrial tissues compared with control (P < 0.05) in vitro. Pretreatment of myometrial strips with PGRMC1 antibody, suppresses the P4-induced relaxation (P < 0.05). PGRMC1 may mediate the non-genomic action of P4 and the relaxation effect on human myometrium during pregnancy. A decrease in PGRMC1 during term or preterm labour might contribute to the 'functional withdrawal' of P4 action and shift the balance to a state of heightened uterine contractility.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21131300     DOI: 10.1093/molehr/gaq096

Source DB:  PubMed          Journal:  Mol Hum Reprod        ISSN: 1360-9947            Impact factor:   4.025


  16 in total

Review 1.  Progestin therapy to prevent preterm birth: History and effectiveness of current strategies and development of novel approaches.

Authors:  Sam A Mesiano; Gregory A Peters; Peyvand Amini; Rachel A Wilson; Gregory P Tochtrop; Focco van Den Akker
Journal:  Placenta       Date:  2019-01-28       Impact factor: 3.481

2.  Progesterone receptor membrane components: key regulators of fetal membrane integrity.

Authors:  Violetta Lozovyy; Lauren Richardson; George Saade; Ramkumar Menon
Journal:  Biol Reprod       Date:  2021-02-11       Impact factor: 4.285

3.  Conditional Ablation of Progesterone Receptor Membrane Component 2 Causes Female Premature Reproductive Senescence.

Authors:  Nicole C Clark; Cindy A Pru; Siu-Pok Yee; John P Lydon; John J Peluso; James K Pru
Journal:  Endocrinology       Date:  2017-03-01       Impact factor: 4.736

4.  Roles of Progesterone Receptor Membrane Component 1 in Oxidative Stress-Induced Aging in Chorion Cells.

Authors:  Liping Feng; Terrence K Allen; William P Marinello; Amy P Murtha
Journal:  Reprod Sci       Date:  2018-05-21       Impact factor: 3.060

5.  Reversible EMT and MET mediate amnion remodeling during pregnancy and labor.

Authors:  Lauren S Richardson; Robert N Taylor; Ramkumar Menon
Journal:  Sci Signal       Date:  2020-02-11       Impact factor: 8.192

6.  Decreased expression of progesterone receptor membrane component 1 in fetal membranes with chorioamnionitis among women with preterm birth.

Authors:  Soo Ran Choi; Hyung Eun Choi; Eunae Jo; Hwa Yeon Choi; Sukyung Jung; Shina Jang; Suk Jin Choi; Sung Ook Hwang
Journal:  Arch Gynecol Obstet       Date:  2020-03-06       Impact factor: 2.344

7.  Expression of progesterone receptor membrane component-1 in bovine reproductive system during estrous cycle.

Authors:  A M Luciano; D Corbani; V Lodde; I Tessaro; F Franciosi; J J Peluso; S Modina
Journal:  Eur J Histochem       Date:  2011-08-27       Impact factor: 3.188

Review 8.  Use of progesterone and progestin analogs for inhibition of preterm birth and other uterine contractility disorders.

Authors:  R E Garfield; L Shi; S-Q Shi
Journal:  Facts Views Vis Obgyn       Date:  2012

9.  Expression of nuclear progesterone receptor and progesterone receptor membrane components 1 and 2 in the oviduct of cyclic and pregnant cows during the post-ovulation period.

Authors:  Marie Saint-Dizier; Olivier Sandra; Stéphane Ployart; Martine Chebrout; Fabienne Constant
Journal:  Reprod Biol Endocrinol       Date:  2012-09-07       Impact factor: 5.211

10.  Progesterone acts via the nuclear glucocorticoid receptor to suppress IL-1β-induced COX-2 expression in human term myometrial cells.

Authors:  Kaiyu Lei; Li Chen; Ektoras X Georgiou; Suren R Sooranna; Shirin Khanjani; Jan J Brosens; Phillip R Bennett; Mark R Johnson
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.